[{"Assets_0_Q2_USD":673481000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-84712000.0,"NetIncomeLoss_1_Q2_USD":-30284000.0,"NetIncomeLoss_2_Q2_USD":-72434000.0,"StockholdersEquity_0_Q2_USD":445134000.0,"Ticker":"SGMO","CIK":"1001233","name":"SANGAMO THERAPEUTICS, INC","OfficialName":"Sangamo Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"750923571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]